We are live on ! Find out more

Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
AKTS icon
401
Aktis Oncology
AKTS
$886M
$886M $15.93 5.46%
ALMS icon
402
Alumis Inc
ALMS
$871M
$871M $6.73 2.32%
PHAR icon
403
Pharming Group
PHAR
$866M
$866M $12.23 0.82%
IVA icon
404
Inventiva
IVA
$862M
$862M $3.65 2.14%
PRME icon
405
Prime Medicine
PRME
$856M
$856M $4.72 9.92%
CRVS icon
406
Corvus Pharmaceuticals
CRVS
$844M
$844M $10.03 1.96%
ABUS icon
407
Arbutus Biopharma
ABUS
$834M
$834M $4.21 1.64%
PACB icon
408
Pacific Biosciences
PACB
$808M
$808M $2.60 10.3%
KIDS icon
409
OrthoPediatrics
KIDS
$806M
$806M $30.87 2.06%
CTKB icon
410
Cytek Biosciences
CTKB
$797M
$797M $6.13 2.7%
VREX icon
411
Varex Imaging
VREX
$783M
$783M $18.43 0.05%
ARDX icon
412
Ardelyx
ARDX
$782M
$782M $3.03 2.26%
AHCO icon
413
AdaptHealth
AHCO
$775M
$775M $5.81 2.02%
COLL icon
414
Collegium Pharmaceutical
COLL
$775M
$775M $23.80 0.96%
HELP
415
Helus Pharma Inc. Common Stock
HELP
$775M
$775M $10.60 1.03%
PHR icon
416
Phreesia
PHR
$772M
$772M $12.44 0.72%
SANA icon
417
Sana Biotechnology
SANA
$769M
$769M $2.57 5.51%
ANNX icon
418
Annexon
ANNX
$768M
$768M $4.05 1%
INMD icon
419
InMode
INMD
$761M
$761M $13.22 2.15%
DNA icon
420
Ginkgo Bioworks
DNA
$755M
$755M $11.21 12%
OABI icon
421
OmniAb
OABI
$743M
$743M $5.11 2.29%
AVBP icon
422
ArriVent BioPharma
AVBP
$733M
$733M $14.87 6.77%
WVE icon
423
Wave Life Sciences
WVE
$708M
$708M $3.59 1.1%
ACHV icon
424
Achieve Life Sciences
ACHV
$704M
$704M $6.83 5.01%
SGMT icon
425
Sagimet Biosciences
SGMT
$703M
$703M $9.92 4.89%
15 16
17
18 19

Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 1,119 Healthcare sector stocks tracked by Wall St. Rank, worth a combined $10T.

The largest by market cap are Eli Lilly (LLY) at $1.26T, Johnson & Johnson (JNJ) at $658B and AbbVie (ABBV) at $521B.

Among institutional investors, UnitedHealth (UNH) drew the most net new fund positions in Q2 2026: 531 funds opened new positions, taking total fund holders up 348 (11%) quarter-over-quarter.

  • Combined market cap: $10T across 1,119 stocks.
  • Largest constituent: Eli Lilly (LLY), $1.26T market cap.
  • Most net new fund positions in Q2 2026: UnitedHealth (UNH), +348 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.